PEDRO P GRANADILLO Insider Trading $HAE HAEMONETICS CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PEDRO P GRANADILLO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PEDRO P GRANADILLO. PEDRO P GRANADILLO is Director in FIRST INDIANA CORP ($FINB) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Director in HAEMONETICS CORP ($HAE) and in ROCKET PHARMACEUTICALS, INC. ($RCKT) and Director in ROCKET PHARMACEUTICALS, INC. ($RCKT).
PEDRO P GRANADILLO in HAEMONETICS CORP
Trading Symbol: HAEIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PEDRO P GRANADILLO: Director
Holdings: 15,335 shares
Current Value: $569,695
Latest Transaction: Nov 09 2018
$HAE Market Capitalization: $1.91B
$HAE Previous Close: $37.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PEDRO P GRANADILLO in HAEMONETICS CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FINB, HAE, NPSP, RCKT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 09 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 114.50 | 12,322 | 1,410,869 | 15,335 | 27.7 K to 15.3 K (-44.55 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 35.50 | 10,353 | 367,532 | 0 | |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 45.45 | 6,573 | 298,743 | 0 | |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 114.16 | 631 | 72,035 | 27,657 | 28.3 K to 27.7 K (-2.23 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 113.16 | 11,812 | 1,336,646 | 28,288 | 40.1 K to 28.3 K (-29.46 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 111.33 | 13,183 | 1,467,663 | 40,100 | 53.3 K to 40.1 K (-24.74 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 110.11 | 3,696 | 406,967 | 53,283 | 57 K to 53.3 K (-6.49 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 108.92 | 1,502 | 163,598 | 56,979 | 58.5 K to 57 K (-2.57 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 35.50 | 10,353 | 367,532 | 58,481 | 48.1 K to 58.5 K (+21.51 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 45.45 | 6,573 | 298,743 | 48,128 | 41.6 K to 48.1 K (+15.82 %) |
Sep 19 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 36.37 | 8,196 | 298,089 | 41,555 | 33.4 K to 41.6 K (+24.57 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.00 | 1,696 | 0 | 33,359 | 31.7 K to 33.4 K (+5.36 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 34.41 | 7,118 | 244,895 | 0 | |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.10 | 40 | 2,284 | 32,381 | 32.4 K to 32.4 K (-0.12 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.09 | 200 | 11,418 | 32,421 | 32.6 K to 32.4 K (-0.61 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.08 | 200 | 11,416 | 32,621 | 32.8 K to 32.6 K (-0.61 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.07 | 100 | 5,707 | 32,821 | 32.9 K to 32.8 K (-0.30 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.07 | 760 | 43,373 | 32,921 | 33.7 K to 32.9 K (-2.26 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.06 | 200 | 11,412 | 33,681 | 33.9 K to 33.7 K (-0.59 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.06 | 4,100 | 233,926 | 33,881 | 38 K to 33.9 K (-10.79 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.05 | 9 | 513 | 37,981 | 38 K to 38 K (-0.02 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.03 | 100 | 5,703 | 37,990 | 38.1 K to 38 K (-0.26 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.02 | 91 | 5,189 | 38,090 | 38.2 K to 38.1 K (-0.24 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.02 | 100 | 5,702 | 38,181 | 38.3 K to 38.2 K (-0.26 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.01 | 100 | 5,701 | 38,281 | 38.4 K to 38.3 K (-0.26 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.01 | 100 | 5,701 | 38,381 | 38.5 K to 38.4 K (-0.26 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.00 | 300 | 17,100 | 38,481 | 38.8 K to 38.5 K (-0.77 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 34.41 | 7,118 | 244,895 | 38,781 | 31.7 K to 38.8 K (+22.48 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.13 | 100 | 5,713 | 32,281 | 32.4 K to 32.3 K (-0.31 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.13 | 100 | 5,713 | 32,181 | 32.3 K to 32.2 K (-0.31 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.14 | 100 | 5,714 | 32,081 | 32.2 K to 32.1 K (-0.31 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.15 | 100 | 5,715 | 31,981 | 32.1 K to 32 K (-0.31 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.17 | 200 | 11,434 | 31,781 | 32 K to 31.8 K (-0.63 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.18 | 18 | 1,029 | 31,763 | 31.8 K to 31.8 K (-0.06 %) |
Dec 04 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 57.23 | 100 | 5,723 | 31,663 | 31.8 K to 31.7 K (-0.31 %) |
Jul 31 2017 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 39.27 | 4,329 | 170,000 | 31,663 | 27.3 K to 31.7 K (+15.84 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.00 | 4,337 | 0 | 21,632 | 17.3 K to 21.6 K (+25.08 %) |
Page: 1